SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001694665-21-000142
Filing Date
2021-10-28
Accepted
2021-10-28 07:06:12
Documents
68
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q evlo-20210930.htm   iXBRL 10-Q 1576764
2 EX-31.1 eveloq3202110-qexhibit311.htm EX-31.1 16278
3 EX-31.2 eveloq3202110-qexhibit312.htm EX-31.2 16915
4 EX-32.1 eveloq3202110-qexhibit321.htm EX-32.1 8369
5 EX-32.2 eveloq3202110-qexhibit322.htm EX-32.2 8355
  Complete submission text file 0001694665-21-000142.txt   6418870

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evlo-20210930.xsd EX-101.SCH 43442
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT evlo-20210930_cal.xml EX-101.CAL 51635
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evlo-20210930_def.xml EX-101.DEF 227395
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evlo-20210930_lab.xml EX-101.LAB 587967
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evlo-20210930_pre.xml EX-101.PRE 375721
11 EXTRACTED XBRL INSTANCE DOCUMENT evlo-20210930_htm.xml XML 826271
Mailing Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139 617 870 8281
Evelo Biosciences, Inc. (Filer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38473 | Film No.: 211355016
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences